.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Tuberculosis (TB) remains a leading cause of mortality across the globe, especially in high-burden regions like India. While the primary Bacillus Calmette-Guérin (BCG) vaccine provides essential protection for children, clinical researchers continue to debate the BCG revaccination efficacy in adults. A comprehensive systematic review and meta-analysis recently investigated whether a second dose of BCG truly strengthens the defense against Mycobacterium tuberculosis (MTB).
The analysis included six randomized controlled trials involving 2,400 participants to evaluate the clinical impact of revaccination. Notably, the study found that BCG revaccination did not result in a significant reduction in initial QuantiFERON (QFT) conversion (RR 0.99). Furthermore, the effect on sustained QFT conversion remained limited (RR 0.80), indicating only modest overall effectiveness. Consequently, these results suggest that the current revaccination strategy may not be sufficient to prevent MTB infection in high-risk populations.
The immunogenicity data revealed a distinct gap between immune markers and clinical outcomes. Researchers observed a moderate increase in CD8+ T cell and cytokine-producing CD4+ T cell responses. However, this robust immune activation did not translate into quantifiable protection against infection. Additionally, safety analysis indicated an increase in localized adverse events among revaccinated individuals. Interestingly, the data also highlighted a reduced risk of upper respiratory tract infections (RR 0.37), pointing toward potential non-specific protective effects of the vaccine.
Overall, the findings underscore the need for next-generation vaccines with proven protective immunity. While BCG revaccination induces cellular immune responses, its inability to significantly prevent QFT conversion suggests it should not be the sole focus for adult TB prevention. Therefore, clinicians must stay updated on emerging vaccine candidates that may offer more reliable protection for vulnerable groups.
According to the latest meta-analysis, BCG revaccination shows no significant effect on initial QFT conversion and only modest effectiveness against sustained infection, suggesting limited protective value.
Revaccination is associated with an increased risk of localized adverse events, such as pain or swelling at the injection site, though it may unexpectedly reduce the risk of certain respiratory infections.
The study highlights a discrepancy where BCG boosts specific T-cell and cytokine responses, but these markers do not always correlate with a lower risk of acquiring or sustaining an MTB infection.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Ali SH et al. Efficacy, immunogenicity, and safety of BCG revaccination against Mycobacterium tuberculosis: A systematic review and meta-analysis. Hum Vaccin Immunother. 2026 Dec undefined. doi: 10.1080/21645515.2026.2630512. PMID: 41689765.
Schmidt AC et al. BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection. N Engl J Med. 2025 May 8;392(19):1797-1808. doi: 10.1056/NEJMoa2400843.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A meta-analysis of six RCTs reveals that BCG revaccination offers limited protection against MTB infection despite significant activation of T-cell response...
5 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
